|
1
|
Cetin O, Guzel Ozdemir P, Kurdoglu Z and
Sahin HG: Investigation of maternal psychopathological symptoms,
dream anxiety and insomnia in preeclampsia. J Matern Fetal Neonatal
Med. 30:2510–2515. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sones JL and Davisson RL: Preeclampsia, of
mice and women. Physiol Genomics. 48:565–572. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Baumwell S and Karumanchi SA:
Pre-eclampsia: Clinical manifestations and molecular mechanisms.
Nephron Clin Pract. 106:c72–c81. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Brooks SA, Martin E, Smeester L, Grace MR,
Boggess K and Fry RC: miRNAs as common regulators of the
transforming growth factor (TGF)-β pathway in the preeclamptic
placenta and cadmium-treated trophoblasts: Links between the
environment, the epigenome and preeclampsia. Food Chem Toxicol.
98:50–57. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zuckerwise L, Li J, Lu L, Men Y, Geng T,
Buhimschi CS, Buhimschi IA, Bukowski R, Guller S, Paidas M and
Huang Y: H19 long noncoding RNA alters trophoblast cell migration
and invasion by regulating TβR3 in placentae with fetal growth
restriction. Oncotarget. 7:38398–38407. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gao F, Bian F, Ma X, Kalinichenko VV and
Das SK: Control of regional decidualization in implantation: Role
of FoxM1 downstream of Hoxa10 and cyclin D3. Sci Rep.
5(13863)2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Xie Y, Cui D, Sui L, Xu Y, Zhang N, Ma Y,
Li Y and Kong Y: Induction of forkhead box M1 (FoxM1) by EGF
through ERK signaling pathway promotes trophoblast cell invasion.
Cell Tissue Res. 362:421–430. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Vaswani K, Hum MW, Chan HW, Ryan J,
Wood-Bradley RJ, Nitert MD, Mitchell MD, Armitage JA and Rice GE:
The effect of gestational age on angiogenic gene expression in the
rat placenta. PloS One. 8(e83762)2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Massimiani M, Salvi S, Piccirilli D and
Vecchione L: A4. EGFL7 in placenta trophoblast and endothelial
cells: Implications in the pathogenesis of pre-eclampsia. J
Maternal Fetal Med. 29:4. 2016.
|
|
10
|
Shah DA and Khalil RA: Bioactive factors
in uteroplacental and systemic circulation link placental ischemia
to generalized vascular dysfunction in hypertensive pregnancy and
preeclampsia. Biochem Pharmacol. 95:211–226. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Knofler M and Pollheimer J: IFPA Award in
Placentology lecture: molecular regulation of human trophoblast
invasion. Placenta. 33 (Suppl):S55–S62. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ji L, Brkic J, Liu M, Fu G, Peng C and
Wang YL: Placental trophoblast cell differentiation: physiological
regulation and pathological relevance to preeclampsia. Mol Aspects
Med. 34:981–1023. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gao F, Feng J, Yao H, Li Y, Xi J and Yang
J: LncRNA SBF2-AS1 promotes the progression of cervical cancer by
regulating miR-361-5p/FOXM1 axis. Artif Cells Nanomed Biotechnol.
47:776–782. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xia N, Tan WF, Peng QZ and Cai HN:
MiR-374b reduces cell proliferation and cell invasion of cervical
cancer through regulating FOXM1. Eur Rev Med Pharmacol Sci.
23:513–521. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhu H: Forkhead box transcription factors
in embryonic heart development and congenital heart disease. Life
Sci. 144:194–201. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The microRNA.org resource: Targets and expression.
Nucleic Acids Res. 36:D149–D153. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 12(4)2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang Z, Tang D, Wang B, Wang Z and Liu M:
Analysis of miRNA-mRNA regulatory network revealed key genes
induced by aflatoxin B1 exposure in primary human hepatocytes. Mol
Genet Genomic Med. 7(e971)2019.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Rehmsmeier M, Steffen P, Hochsmann M and
Giegerich R: Fast and effective prediction of microRNA/target
duplexes. RNA. 10:1507–1517. 2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Guibourdenche J, Leguy MC and Tsatsaris V:
Biology and markers of preeclampsia. Ann Biol Clin (Paris).
71:79–87. 2013.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
23
|
van Beek E and Peeters LL: The
pathogenesis of preeclampsia. Ned Tijdschr Geneeskd. 141:1379–1384.
1997.PubMed/NCBI(In Dutch).
|
|
24
|
Nissaisorakarn P, Sharif S and Jim B:
Hypertension in pregnancy: Defining blood pressure goals and the
value of biomarkers for preeclampsia. Curr Cardiol Rep.
18(131)2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Goldman-Wohl DS and Yagel S: Examination
of distinct fetal and maternal molecular pathways suggests a
mechanism for the development of preeclampsia. J Reprod Immunol.
76:54–60. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Austgulen R: Recent knowledge on
mechanisms underlying development of pre-eclampsia. Tidsskr Nor
Laegeforen. 124:21–24. 2004.PubMed/NCBI(In Norwegian).
|
|
27
|
Xuan RR, Niu TT and Chen HM: Astaxanthin
blocks preeclampsia progression by suppressing oxidative stress and
inflammation. Mol Med Rep. 14:2697–2704. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bokslag A, van Weissenbruch M, Mol BW and
de Groot CJ: Preeclampsia; Short and long-term consequences for
mother and neonate. Early Hum Dev. 102:47–50. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gilani SI, Weissgerber TL, Garovic VD and
Jayachandran M: Preeclampsia and extracellular vesicles. Curr
Hypertens Rep. 18(68)2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Karumanchi SA and Granger JP: Preeclampsia
and pregnancy-related hypertensive disorders. Hypertension.
67:238–242. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Nestal de Moraes G, Bella L, Zona S,
Burton MJ and Lam EW: Insights into a critical role of the
FOXO3a-FOXM1 Axis in DNA damage response and genotoxic drug
resistance. Curr Drug Targets. 17:164–177. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zona S, Bella L, Burton MJ, Nestal de
Moraes G and Lam EW: FOXM1: An emerging master regulator of DNA
damage response and genotoxic agent resistance. Biochim Biophys
Acta. 1839:1316–1322. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zou AX, Chen B, Li QX and Liang YC:
MiR-134 inhibits infiltration of trophoblast cells in placenta of
patients with preeclampsia by decreasing ITGB1 expression. Eur Rev
Med Pharmacol Sci. 22:2199–2206. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cantini L, Isella C, Petti C, Picco G,
Chiola S, Ficarra E, Caselle M and Medico E: MicroRNA-mRNA
interactions underlying colorectal cancer molecular subtypes. Nat
Commun. 6(8878)2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Nakamura T, Canaani E and Croce CM:
Oncogenic All1 fusion proteins target Drosha-mediated microRNA
processing. Proc Natl Acad Sci USA. 104:10980–10985.
2007.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Feber A, Xi L, Luketich JD, Pennathur A,
Landreneau RJ, Wu M, Swanson SJ, Godfrey TE and Litle VR: MicroRNA
expression profiles of esophageal cancer. J Thorac Cardiovasc Surg.
135:D255–D260. 2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu C, Yu J, Yu S, Lavker RM, Cai L, Liu
W, Yang K, He X and Chen S: MicroRNA-21 acts as an oncomir through
multiple targets in human hepatocellular carcinoma. J Hepatol.
53:98–107. 2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lui WO, Pourmand N, Patterson BK and Fire
A: Patterns of known and novel small RNAs in human cervical cancer.
Cancer Res. 67:6031–6043. 2007.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Iorio MV, Visone R, Di Leva G, Donati V,
Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, et
al: MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Gombos K, Horvath R, Szele E, Juhász K,
Gocze K, Somlai K, Pajkos G, Ember I and Olasz L: miRNA expression
profiles of oral squamous cell carcinomas. Anticancer Res.
33:1511–1517. 2013.PubMed/NCBI
|
|
41
|
Odar K, Boštjančič E, Gale N, Glavač D and
Zidar N: Differential expression of microRNAs miR-21, miR-31,
miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in
verrucous carcinoma of the head and neck. Histopathology.
61:257–265. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ciafre SA, Galardi S, Mangiola A, Ferracin
M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Fulci V, Chiaretti S, Goldoni M, Azzalin
G, Carucci N, Tavolaro S, Castellano L, Magrelli A, Citarella F,
Messina M, et al: Quantitative technologies establish a novel
microRNA profile of chronic lymphocytic leukemia. Blood.
109:4944–4951. 2007.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K
and Yang GH: MicroRNA-21 (miR-21) represses tumor suppressor PTEN
and promotes growth and invasion in non-small cell lung cancer
(NSCLC). Clin Chim Acta. 411:846–852. 2010.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Gibcus JH, Tan LP, Harms G, Schakel RN, de
Jong D, Blokzijl T, Möller P, Poppema S, Kroesen BJ and van den
Berg A: Hodgkin lymphoma cell lines are characterized by a specific
miRNA expression profile. Neoplasia. 11:167–176. 2009.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Tran N, McLean T, Zhang X, Zhao CJ,
Thomson JM, O'Brien C and Rose B: MicroRNA expression profiles in
head and neck cancer cell lines. Biochem Biophys Res Commun.
358:12–17. 2007.PubMed/NCBI View Article : Google Scholar
|
